Who owns Engene Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Engene Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Engene Therapeutics stock

Who bought or sold Engene Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Marshall Wace 344k $2.3M 100% Mar 2026
 View chart
Marquette Asset Management 151k $260k 100% Jun 2026
 View chart
SBI Securities 28.00 $190.999200 100% Mar 2026
 View chart